Elevation Oncology Inc (ELEV)
US$ 0.839426.47%
Price Chart
Key Statistics
Market Cap
$ 22.26M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
7.79M
52W High
$ 4.48
52W Low
$ 0.22
Dividend Yield
0.00%
Beta
1.67
Technicals
50-Day MA
0.4165
200-Day MA
0.7791
52 Week High
4.48
52 Week Low
0.221
About ELEV
Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs.
Employees
34
Headquarters
Boston, MA
CEO
Mr. Joseph J. Ferra Jr.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg